罗亚
血小板
调节器
血小板活化
血栓形成
细胞生物学
化学
小型GTPase
信号转导
受体
CDC42型
下调和上调
药理学
GTP酶
癌症研究
内皮
抑制性突触后电位
血小板因子4
医学
内科学
原癌基因酪氨酸蛋白激酶Src
负调节器
血小板粘附
内分泌学
病变
作者
Yangdong Ding,Linmin Pan,Chen Jie,Yanxu Jiang,Linfeng Liu,Jin Zhang,Mingtong Chen,Junjie Zhu,Yue Gao,Wenwu Zhang,Junjie Liang,Puhong Zhang,Shengwei Jin
出处
期刊:Cell Reports
[Cell Press]
日期:2026-11-01
卷期号:45 (11): 118284-118284
标识
DOI:10.1016/j.celrep.2026.118284
摘要
Vascular endothelial growth factor receptor 3 (VEGFR3) is a key regulator of lymphangiogenesis, but its role in platelets remains undefined. Here, we identify VEGFR3 as an intrinsic inhibitory regulator of platelet function. Using PF4-Cre-mediated conditional deletion, pharmacological inhibition, and biochemical analyses, we show that VEGFR3 deficiency enhances platelet activation, aggregation, secretion, cytoskeletal remodeling, thrombosis, and myocardial injury. Mechanistically, VEGFR3 interacts with the Rho GTPase regulator p190A to limit RhoA activation and Ezrin/Radixin/Moesin phosphorylation, thereby restraining platelet activation. In patients with myocardial infarction, reduced platelet VEGFR3 expression is associated with increased platelet reactivity and greater coronary lesion severity. These findings uncover a previously unrecognized VEGFR3/p190A/RhoA signaling axis that restrains platelet activation and thrombosis and highlight its potential therapeutic relevance in thrombotic disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI